# EDGAR Filing Document

**Accession Number:** 0002023016
**File Stem:** 0000000000-25-010348
**Filing Date:** 2025-9
**Character Count:** 3388
**Document Hash:** 274c53187e742297ae202593370cb7ff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-010348.hdr.sgml**: 20260224

**ACCESSION NUMBER**: 0000000000-25-010348

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250923

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Turn Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0002023016
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 320456090
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-08130

**BUSINESS ADDRESS:**
- **STREET 1:** 250 NORTH WESTLAKE BLVD.
- **STREET 2:** #210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362
- **BUSINESS PHONE:** 8185644011

**MAIL ADDRESS:**
- **STREET 1:** 250 N. WESTLAKE BLVD.
- **STREET 2:** #210
- **CITY:** WESTLAKE VILLAGE
- **STATE:** CA
- **ZIP:** 91362

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Global Health Solutions, Inc
- **DATE OF NAME CHANGE:** 20240510
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001104659-25-061163

## Text-Extract

```

                                                            September 23, 2025

Bradley Burnam
Chief Executive Officer
Global Health Solutions, Inc.
250 N. Westlake Blvd.
Westlake Village, CA 91362

        Re: Global Health Solutions, Inc.
            Amendment No. 1 to Registration Statement on Form S-1
            Filed September 16, 2025
            File No. 333-289972
Dear Bradley Burnam:

     We have reviewed your amended registration statement and have the
following
comment.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe our comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Amendment No. 1 to Registration Statement on Form S-1
Description of Capital Stock
Common Stock, page 105

1.     You disclose that in connection with the effectiveness of the
registration statement
       and before the completion of the offering, a 2-for-1 forward stock split
of your
       common stock will be effected. Please confirm whether it will be
effected prior to
       effectiveness of your registration statement. If so, please revise your
financial
       statements to reflect the forward stock split in accordance with ASC
260-10-55-12
       and SAB Topic 4:C. and have your auditor dual date the report for the
impact of the
       split.
        Please contact Vanessa Robertson at 202-551-3649 or Sasha Parikh at
202-551-3627
if you have questions regarding comments on the financial statements and
related
 September 23, 2025
Page 2

matters. Please contact Alan Campbell at 202-551-4224 or Joe McCann at
202-551-6262
with any other questions.

                                                       Sincerely,

                                                       Division of Corporation
Finance
                                                       Office of Life Sciences
cc:   Stephen A. Byeff

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._